The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter

BMC Medical Informatics and Decision Making

Volumn 14, Issue 1, 2014, Pages

  Barton, Jennifer L ^a,b   Koenig, Christopher J ^a   Evans Young, Gina ^a,c   Trupin, Laura ^a,c   Anderson, Jennie ^d   Ragouzeos, Dana ^d   Breslin, Maggie ^d   Morse, Timothy ^d   Schillinger, Dean ^a   Montori, Victor M ^e   Yelin, Edward H ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Mayo Clinic ^*  (United States)

^e MAYO CLINIC   (United States)

Author keywords

Decision aid; Health literacy; Rheumatoid arthritis

Indexed keywords

ADULT; ARTHRITIS, RHEUMATOID; DECISION MAKING; DECISION SUPPORT SYSTEM; HEALTH LITERACY; HUMAN;

ADULT; ARTHRITIS, RHEUMATOID; DECISION MAKING; DECISION SUPPORT TECHNIQUES; HEALTH LITERACY; HUMANS;

EID: 84928752926     PISSN: None     EISSN: 14726947     Source Type: Journal    
DOI: 10.1186/s12911-014-0104-8     Document Type: Article

References (45)

1. Soliman MM, Ashcroft DM, Watson KD, Lunt M, Symmons DP, Hyrich KL: British Society for Rheumatology Biologics R. Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011, 70(4):583-589. doi:10.1136/ard.2010.139774. PubMed PMID: 21330639; PubMed Central PMCID: PMC3048625.
2. McBurney CA, Vina ER: Racial and ethnic disparities in rheumatoid arthritis. Curr Rheumatol Rep 2012, 14(5):463-471. Epub 2012/07/10. doi:10.1007/s11926-012-0276-0. PubMed PMID: 22773376.
3. Bruce B, Fries JF, Murtagh KN: Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol 2007, 34(7):1475-1479. Epub 2007/06/07. PubMed PMID: 17552045.
4. Barton JL, Trupin L, Schillinger D, Gansky SA, Tonner C, Margaretten M, Chernitskiy V, Graf J, Imboden J, Yelin E: Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics. Arthritis Care Res (Hoboken) 2011, 63(9):1238-1246. Epub 2011/06/15. doi:10.1002/acr.20525. PubMed PMID: 21671414; PubMed Central PMCID: PMC3169768.
5. Caplan L, Wolfe F, Michaud K, Quinzanos I, Hirsh JM: Strong association of health literacy with functional status among rheumatoid arthritis patients: a cross-sectional study. Arthritis Care Res (Hoboken) 2014, 66(4):508-514. Epub 2013/09/12. doi:10.1002/acr.22165. PubMed PMID: 24023051.
6. Barton JL, Trupin L, Tonner C, Imboden J, Katz P, Schillinger D, Yelin E: English language proficiency, health literacy, and trust in physician are associated with shared decision making in rheumatoid arthritis. J Rheumatol 2014, 41(7):7-1290. doi:10.3899/jrheum.131350. PubMed PMID: 24931952.
7. De Wit MP, Smolen JS, Gossec L, Van Der Heijde DM: Treating rheumatoid arthritis to target: the patient version of the international recommendations. Ann Rheum Dis 2011, 70(6):891-895. Epub 2011/04/12. doi:10.1136/ard.2010.146662. PubMed PMID: 21478190; PubMed Central PMCID: PMC3086033.
8. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, De Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, Van Der Heijde D: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010, 69(4):631-637. Epub 2010/03/11. doi:10.1136/ard.2009.123919. PubMed PMID: 20215140; PubMed Central PMCID: PMC3015099.
9. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, Van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, et al: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010, 69(6):964-975. Epub 2010/05/07. doi:10.1136/ard.2009.126532. PubMed PMID: 20444750; PubMed Central PMCID: PMC2935329.
10. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, De Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, Van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, et al: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014, 73(3):492-509. Epub 2013/10/29. doi:10.1136/annrheumdis-2013-204573. PubMed PMID: 24161836; PubMed Central PMCID: PMC3933074.
11. Breslin M, Mullan RJ, Montori VM: The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. Patient Educ Couns 2008, 73(3):465-472. Epub 2008/09/06. doi:10.1016/j.pec.2008.07.024. PubMed PMID: 18771876.
12. Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, Perestelo-Perez LI, Stroebel RJ, Yawn BP, Yapuncich V, Breslin MA, Pencille L, Smith SA: The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med 2009, 169(17):1560-1568. Epub 2009/09/30. doi:10.1001/archinternmed.2009.293. PubMed PMID: 19786674.
13. Jagosh J, Macaulay AC, Pluye P, Salsberg J, Bush PL, Henderson J, Sirett E, Wong G, Cargo M, Herbert CP, Seifer SD, Green LW, Greenhalgh T: Uncovering the benefits of participatory research: implications of a realist review for health research and practice. Milbank Q 2012, 90(2):311-346. Epub 2012/06/20. doi:10.1111/j.1468-0009.2012.00665.x. PubMed PMID: 22709390; PubMed Central PMCID: PMC3460206.
14. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG: 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012, 64(5):625-639. Epub 2012/04/05. doi:10.1002/acr.21641. PubMed PMID: 22473917.
15. O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E: Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 2013, 369(4):307-318. Epub 2013/06/13. doi:10.1056/NEJMoa1303006. PubMed PMID: 23755969.
16. Charmaz K: 'Discovering' chronic illness: using grounded theory. Soc Sci Med 1990, 30(11):1161-1172. PubMed PMID: 2360052.
17. Barton JL, Koenig CJ, Trupin L, Evans-Young G, Schillinger D, Yelin E: Patient preferences and values associated with therapeutic options for rheumatoid arthritis: A qualitative study of patients and provider stakeholders across three languages. St. Andrews, Scotland: International Conference on Communication in Healthcare; 2012.
18. Seligman HK, Wallace AS, DeWalt DA, Schillinger D, Arnold CL, Shilliday BB, Delgadillo A, Bengal N, Davis TC: Facilitating behavior change with low-literacy patient education materials. Am J Health Behav 2007, 31(Suppl 1):S69-S78. Epub 2007/10/20. doi:10.5555/ajhb.2007.31.supp. S69. PubMed PMID: 17931139.
19. Bandura A: Health promotion by social cognitive means. Health Educ Behav 2004, 31(2):143-164. Epub 2004/04/20. doi:10.1177/1090198104263660. PubMed PMID: 15090118.
20. Choosing Medications for Rheumatoid Arthritis: Clinician's Guide. Rockville (MD): Comparative Effectiveness Review Summary Guides for Clinicians; 2007.
21. Rheumatoid Arthritis Medicines: A Guide for Adults. Rockville (MD): Comparative Effectiveness Review Summary Guides for Consumers; 2005.
22. Aaltonen KJ, Virkki LM, Malmivaara A, Konttinen YT, Nordstrom DC, Blom M: Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS One 2012, 7(1):e30275. Epub 2012/01/25. doi:10.1371/journal.pone.0030275. PubMed PMID: 22272322; PubMed Central PMCID: PMC3260264.
23. Katchamart W, Trudeau J, Phumethum V, Bombardier C: Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2009, 68(7):1105-1112. Epub 2008/12/05. doi:10.1136/ard.2008.099861. PubMed PMID: 19054823; PubMed Central PMCID: PMC2689526.
24. Katchamart W, Trudeau J, Phumethum V, Bombardier C: Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis. Cochrane Database Syst Rev 2010, 4: CD008495. Epub 2010/04/16. doi:10.1002/14651858. CD008495. PubMed PMID: 20393970.
25. Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, Van Der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martin-Mola EM, Mielants H, Muller-Ladner U, Murphy G, Ostergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M: Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009, 68(7):1086-1093. Epub 2008/11/27. doi:10.1136/ard.2008.094474. PubMed PMID: 19033291; PubMed Central PMCID: PMC2689523.
26. LeBlanc A, Bodde AE, Branda ME, Yost KJ, Herrin J, Williams MD, Shah ND, Houten HV, Ruud KL, Pencille LJ, Montori VM: Translating comparative effectiveness of depression medications into practice by comparing the depression medication choice decision aid to usual care: study protocol for a randomized controlled trial. Trials 2013, 14:127. Epub 2013/06/21. doi:10.1186/1745-6215-14-127. PubMed PMID: 23782672; PubMed Central PMCID: PMC3663744.
27. Traynor K: FDA approves tofacitinib for rheumatoid arthritis. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 2012, 69(24):2120. doi:10.2146/news120088. PubMed PMID: 23230026.
28. Barton J, Koenig CJ, Trupin L, Evans-Young G, Schillinger D, Yelin E: Patient preferences and values associated with therapeutic options for Rheumatoid Arthritis: A qualitative study of patients and provider stakeholders across three languages. Denver CO: ACR Research Workshop; 2012. May 4-5, 2012.
29. Constantinescu F, Goucher S, Weinstein A, Fraenkel L: Racial disparities in treatment preferences for rheumatoid arthritis. Med Care 2009, 47(3):350-355. Epub 2009/01/24. doi:10.1097/MLR.0b013e31818af829. PubMed PMID: 19165120.
30. Fraenkel L, Bogardus ST, Concato J, Felson DT, Wittink DR: Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis 2004, 63(11):1372-1378. Epub 2004/03/17. doi:10.1136/ard.2003.019422. PubMed PMID: 15020312; PubMed Central PMCID: PMC1754807.
31. Pasma A, Van't Spijker A, Hazes JM, Busschbach JJ, Luime JJ: Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review. Semin Arthritis Rheum 2013, 43(1):18-28. Epub 2013/01/29. doi:10.1016/j.semarthrit.2012.12.001. PubMed PMID: 23352247.
32. Sanderson T, Calnan M, Morris M, Richards P, Hewlett S: The impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative study. Musculoskeletal Care 2009, 7(3):194-209. Epub 2009/01/08. doi:10.1002/msc.149. PubMed PMID: 19127529; PubMed Central PMCID: PMC2886965.
33. Barton JL: Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence 2009, 3:335-344. Epub 2009/12/18. PubMed PMID: 20016797; PubMed Central PMCID: PMC2792871.
34. Fagerlin A, Zikmund-Fisher BJ, Ubel PA: Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst 2011, 103(19):1436-1443. Epub 2011/09/21. doi:10.1093/jnci/djr318. PubMed PMID: 21931068; PubMed Central PMCID: PMC3218625.
35. Chung CP, Thompson JL, Koch GG, Amara I, Strand V, Pincus T: Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities. Ann Rheum Dis 2006, 65(12):1602-1607. Epub 2006/03/01. doi:10.1136/ard.2005.048975. PubMed PMID: 16504992; PubMed Central PMCID: PMC1798472.
36. Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, Gossec L, Landewe R, Smolen JS, Buch MH: Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2014, 73(3):516-528. Epub 2014/01/09. doi:10.1136/annrheumdis-2013-204577. PubMed PMID: 24399231.
37. Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, Bridges SL Jr, Zhang J, McVie T, Howard G, Van Der Heijde D, Cofield SS: A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum 2012, 64(9):2824-2835. Epub 2012/04/18. doi:10.1002/art.34498. PubMed PMID: 22508468; PubMed Central PMCID: PMC4036119.
38. DeWalt DA, Davis TC, Wallace AS, Seligman HK, Bryant-Shilliday B, Arnold CL, Freburger J, Schillinger D: Goal setting in diabetes self-management: taking the baby steps to success. Patient Educ Couns 2009, 77(2):218-223. Epub 2009/04/11. doi:10.1016/j.pec.2009.03.012. PubMed PMID: 19359123.
39. Heisler M, Vijan S, Anderson RM, Ubel PA, Bernstein SJ, Hofer TP: When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? J Gen Intern Med 2003, 18(11):893-902. Epub 2003/12/23. PubMed PMID: 14687274; PubMed Central PMCID: PMC1494939.
40. Maneesriwongul W, Dixon JK: Instrument translation process: a methods review. J Adv Nurs 2004, 48(2):175-186. Epub 2004/09/17. doi:10.1111/j.1365-2648.2004.03185.x. PubMed PMID: 15369498.
41. Stacey D, Legare F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L, Wu JH: Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014, 1: CD001431. Epub 2014/01/29. doi: 10.1002/14651858. CD001431.pub4. PubMed PMID: 24470076.
42. Fraenkel L, Peters E, Charpentier P, Olsen B, Errante L, Schoen RT, Reyna V: Decision tool to improve the quality of care in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012, 64(7):977-985. Epub 2012/03/07. doi:10.1002/acr.21657. PubMed PMID: 22392766; PubMed Central PMCID: PMC3375390.
43. Martin RW, Brower ME, Geralds A, Gallagher PJ, Tellinghuisen DJ: An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis. Patient Educ Couns 2012, 86(3):329-334. Epub 2011/07/15. doi:10.1016/j.pec.2011.06.001. PubMed PMID: 21752570.
44. Li LC, Adam PM, Backman CL, Lineker S, Jones CA, Lacaille D, Townsend AF, Yacyshyn E, Yousefi C, Tugwell P, Leese J, Stacey D. A proof-of-concept study of ANSWER, a web-based methotrexate decision aid for patients with rheumatoid arthritis. Arthritis care & research. 2014. doi:10.1002/acr.22319. PubMed PMID: 24623617
45. Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, Van Der Weijden T: A systematic development process for patient decision aids. BMC Med Inform Decis Mak 2013, 13(Suppl 2):S2.